Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
최신 재무제표(Form-10K)에 따르면, Eagle Point Credit Company Inc의 총 자산은 $0이며, 순손실입니다.
MASI의 주요 재무 비율은 무엇인가요?
Eagle Point Credit Company Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Masimo Corp의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Eagle Point Credit Company Inc 주요 수익원은 T Cell Receptor-engineered T Cell이며, 최신 수익 발표에서 수익은 2,816,000입니다. 지역별로는 United States이 Eagle Point Credit Company Inc의 주요 시장이며, 수익은 2,816,000입니다.
Masimo Corp은 수익성이 있나요?
no, 최신 재무제표에 따르면 Eagle Point Credit Company Inc의 순손실은 $0입니다.